Stock SOBI SWEDISH ORPHAN BIOVITRUM AB
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Swedish Orphan Biovitrum AB

Equities

SOBI

SE0000872095

Market Closed - Nasdaq Stockholm
Other stock markets
 11:29:49 2024-04-26 am EDT 		5-day change 1st Jan Change
281 SEK +0.07% Intraday chart for Swedish Orphan Biovitrum AB +7.66% +5.24%
Apr. 26 Sobi Wins EU Regulatory Panel's Positive Opinion for Hemophilia A Drug MT
Apr. 26 Sobi Receives Positive CHMP Opinion Recommending Approval of efanesoctocog alfa for Once-Weekly Treatment of Haemophilia A CI

Evolution of the average Target Price on Swedish Orphan Biovitrum AB

Price target over the last 5 years

History of analyst recommendation changes

23c7fd.xfOCnegYGtKBZFbGIqj7M3c-fl5l6dV4qTJhBapKYgo.nLz1_7l0cqjwMwGLRMGuXjV8NWYNxJ4Lwn4SPMsYG1D1mvXktywivrMcGw~afe2e7c73468af956140005350cfaff9

Analyst Recommendations on Swedish Orphan Biovitrum AB

Soaring dollar and oil spooks investors Our Logo
European shares edge higher as US CPI data looms, Credit Agricole gains RE
Swedish Orphan Biovitrum : Sobi publishes its Report for the Second Quarter 2015 - raises guidance GL
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
281 SEK
Average target price
317.2 SEK
Spread / Average Target
+12.89%
High Price Target
370 SEK
Spread / Highest target
+31.67%
Low Price Target
252 SEK
Spread / Lowest Target
-10.32%

Consensus detail

Consensus revision (last 18 months)

Ratings for Swedish Orphan Biovitrum AB

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. SOBI Stock
  4. Consensus Swedish Orphan Biovitrum AB